BetterLife Pharma (BETR.CN) Stock Price

BetterLife Pharma Price

CSE·CLOSED
0.31CAD-0.12 (-32.88 %)
Market closed

Earnings per share have declined at 15.6% per year over the last 4 years. The stock trades about 663% above its 52-week low.

BetterLife Pharma stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of BetterLife Pharma over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how BetterLife Pharma stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing BetterLife Pharma's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

BetterLife Pharma Stock Price History
DateBetterLife Pharma Price
8/10/20260.31 CAD
8/7/20260.43 CAD
8/6/20260.40 CAD
8/5/20260.36 CAD
8/4/20260.31 CAD
7/30/20260.24 CAD
7/29/20260.23 CAD
7/28/20260.23 CAD
7/27/20260.24 CAD
7/24/20260.21 CAD
7/23/20260.20 CAD
7/22/20260.23 CAD
7/21/20260.23 CAD
7/20/20260.23 CAD
7/17/20260.22 CAD
7/16/20260.22 CAD
7/15/20260.23 CAD
7/14/20260.20 CAD
7/13/20260.20 CAD
7/10/20260.19 CAD
7/9/20260.19 CAD
7/8/20260.19 CAD
7/7/20260.19 CAD
7/6/20260.19 CAD
7/3/20260.19 CAD
7/2/20260.19 CAD
6/30/20260.16 CAD
6/29/20260.14 CAD
6/26/20260.15 CAD
6/25/20260.12 CAD
6/24/20260.09 CAD
6/23/20260.09 CAD
6/22/20260.08 CAD
6/19/20260.06 CAD
6/18/20260.06 CAD
6/17/20260.06 CAD
6/16/20260.06 CAD
6/15/20260.07 CAD
6/12/20260.07 CAD
6/11/20260.07 CAD
6/10/20260.06 CAD
6/9/20260.06 CAD
6/8/20260.06 CAD
6/5/20260.06 CAD
6/4/20260.06 CAD
6/3/20260.06 CAD
6/2/20260.06 CAD
6/1/20260.06 CAD
5/29/20260.06 CAD
5/28/20260.06 CAD
5/27/20260.06 CAD
5/26/20260.06 CAD
5/25/20260.06 CAD
5/22/20260.06 CAD
5/21/20260.06 CAD
5/20/20260.06 CAD
5/19/20260.06 CAD
5/15/20260.06 CAD
5/14/20260.06 CAD
5/13/20260.06 CAD
5/12/20260.06 CAD
5/11/20260.06 CAD
5/8/20260.06 CAD
5/7/20260.06 CAD
5/6/20260.06 CAD
5/5/20260.06 CAD
5/4/20260.06 CAD
5/1/20260.06 CAD
4/30/20260.06 CAD
4/29/20260.06 CAD
4/28/20260.06 CAD
4/27/20260.06 CAD
4/24/20260.06 CAD
4/23/20260.06 CAD
4/22/20260.07 CAD
4/21/20260.06 CAD
4/20/20260.06 CAD
4/17/20260.06 CAD
4/16/20260.06 CAD
4/15/20260.06 CAD
4/14/20260.06 CAD
4/13/20260.06 CAD
4/10/20260.06 CAD
4/9/20260.06 CAD
4/8/20260.06 CAD
4/7/20260.06 CAD
4/6/20260.06 CAD
4/2/20260.06 CAD
4/1/20260.07 CAD
3/31/20260.07 CAD
3/30/20260.07 CAD
3/27/20260.06 CAD
3/26/20260.06 CAD
3/25/20260.06 CAD
3/24/20260.06 CAD
3/23/20260.06 CAD
3/20/20260.07 CAD
3/19/20260.07 CAD
3/18/20260.08 CAD
3/17/20260.08 CAD
3/16/20260.07 CAD
3/13/20260.07 CAD
3/12/20260.07 CAD
3/11/20260.08 CAD
3/10/20260.07 CAD
3/9/20260.06 CAD
3/6/20260.09 CAD
3/5/20260.07 CAD
3/4/20260.06 CAD
3/3/20260.06 CAD
3/2/20260.06 CAD
2/27/20260.06 CAD
2/26/20260.06 CAD
2/25/20260.06 CAD
2/24/20260.05 CAD
2/23/20260.05 CAD
2/20/20260.05 CAD
2/19/20260.05 CAD
2/18/20260.05 CAD
2/17/20260.05 CAD
2/13/20260.05 CAD
2/12/20260.05 CAD
2/11/20260.05 CAD
2/10/20260.06 CAD
2/9/20260.06 CAD
2/6/20260.06 CAD
2/5/20260.05 CAD
2/4/20260.05 CAD
2/3/20260.05 CAD
2/2/20260.05 CAD
1/30/20260.05 CAD
1/29/20260.05 CAD
1/28/20260.05 CAD
1/27/20260.05 CAD
1/26/20260.05 CAD
1/23/20260.05 CAD
1/22/20260.05 CAD
1/21/20260.05 CAD
1/20/20260.05 CAD
1/19/20260.05 CAD
1/16/20260.05 CAD
1/15/20260.05 CAD
1/14/20260.05 CAD
1/13/20260.05 CAD
1/12/20260.05 CAD
1/9/20260.05 CAD
1/8/20260.05 CAD
1/7/20260.04 CAD
1/6/20260.05 CAD
1/5/20260.05 CAD
1/2/20260.05 CAD
12/31/20250.05 CAD
12/30/20250.05 CAD
12/29/20250.05 CAD
12/24/20250.05 CAD
12/23/20250.05 CAD
12/22/20250.05 CAD
12/19/20250.05 CAD
12/18/20250.05 CAD
12/17/20250.05 CAD
12/16/20250.05 CAD
12/15/20250.05 CAD
12/12/20250.05 CAD
12/11/20250.06 CAD
12/10/20250.05 CAD
12/9/20250.06 CAD
12/8/20250.06 CAD
12/5/20250.05 CAD
12/4/20250.06 CAD
12/3/20250.06 CAD
12/2/20250.06 CAD
12/1/20250.05 CAD
11/28/20250.05 CAD
11/27/20250.05 CAD
11/26/20250.05 CAD
11/25/20250.06 CAD
11/24/20250.05 CAD
11/21/20250.05 CAD
11/20/20250.05 CAD
11/19/20250.06 CAD
11/18/20250.06 CAD
11/17/20250.06 CAD
11/14/20250.06 CAD
11/13/20250.06 CAD
11/12/20250.07 CAD
11/11/20250.06 CAD
11/10/20250.06 CAD
11/7/20250.06 CAD
11/6/20250.06 CAD
11/5/20250.06 CAD
11/4/20250.07 CAD
11/3/20250.06 CAD
10/31/20250.06 CAD
10/30/20250.06 CAD
10/29/20250.06 CAD
10/28/20250.06 CAD
10/27/20250.06 CAD
10/24/20250.06 CAD
10/23/20250.06 CAD
10/22/20250.06 CAD
10/21/20250.06 CAD
10/20/20250.06 CAD
10/17/20250.06 CAD
10/16/20250.06 CAD
10/15/20250.06 CAD
10/14/20250.06 CAD
10/10/20250.06 CAD
10/9/20250.07 CAD
10/8/20250.07 CAD
10/7/20250.07 CAD
10/6/20250.06 CAD
10/3/20250.07 CAD
10/2/20250.08 CAD
10/1/20250.07 CAD
9/30/20250.07 CAD
9/29/20250.08 CAD
9/26/20250.08 CAD
9/25/20250.08 CAD
9/24/20250.08 CAD
9/23/20250.09 CAD
9/22/20250.09 CAD
9/19/20250.09 CAD
9/18/20250.09 CAD
9/17/20250.09 CAD
9/16/20250.09 CAD
9/15/20250.09 CAD
9/12/20250.09 CAD
9/11/20250.09 CAD
9/10/20250.09 CAD
9/9/20250.09 CAD
9/8/20250.09 CAD
9/5/20250.09 CAD
9/4/20250.09 CAD
9/3/20250.09 CAD
9/2/20250.09 CAD
8/29/20250.09 CAD
8/28/20250.09 CAD
8/27/20250.09 CAD
8/26/20250.09 CAD
8/25/20250.09 CAD
8/22/20250.09 CAD
8/21/20250.09 CAD
8/20/20250.09 CAD
8/19/20250.08 CAD
8/18/20250.09 CAD
8/15/20250.09 CAD
8/14/20250.09 CAD
Access this data via the Eulerpool API
Get Free API Key

BetterLife Pharma Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
0.00 CAD
-6.46 M CAD
-9.15 M CAD
Jan 1, 2020
0.00 CAD
-9.20 M CAD
-19.59 M CAD
Jan 1, 2021
0.00 CAD
-7.95 M CAD
-36.35 M CAD
Jan 1, 2022
0.00 CAD
-9.97 M CAD
-12.16 M CAD
Jan 1, 2023
0.00 CAD
-9.26 M CAD
-9.02 M CAD
Jan 1, 2024
0.00 CAD
-3.21 M CAD
-2.89 M CAD
Jan 1, 2025
0.00 CAD
-4.72 M CAD
-3.52 M CAD
Jan 1, 2026
0.00 CAD
-1.81 M CAD
-1.50 M CAD

BetterLife Pharma Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 12:03 PM
 
EBITM CAD
NET INCOMEM CAD
NET INCOME GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026
––-10.002.008.00–-1.00-6.00-9.00-7.00-9.00-9.00-3.00-4.00-1.00
1.00–-11.001.008.00––-9.00-19.00-36.00-12.00-9.00-2.00-3.00-1.00
–––-109.09700.00–––111.1189.47-66.67-25.00-77.7850.00-66.67
6.5317.0477.7211.6077.7277.7277.7277.7277.7277.7277.7277.7277.7277.7277.72
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales BetterLife Pharma generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue BetterLife Pharma retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare BetterLife Pharma's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares BetterLife Pharma has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against BetterLife Pharma's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

BetterLife Pharma stock margins

The BetterLife Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BetterLife Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BetterLife Pharma.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
0.00 %
- %
- %
Jan 1, 2020
0.00 %
- %
- %
Jan 1, 2021
0.00 %
- %
- %
Jan 1, 2022
0.00 %
- %
- %
Jan 1, 2023
0.00 %
- %
- %
Jan 1, 2024
0.00 %
- %
- %
Jan 1, 2025
0.00 %
- %
- %
Jan 1, 2026
0.00 %
- %
- %

BetterLife Pharma Stock Revenue, EBIT, Earnings per Share

The BetterLife Pharma earnings per share therefore indicates how much revenue BetterLife Pharma has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
0.00 CAD
0.00 CAD
0.00 CAD
Jan 1, 2020
0.00 CAD
0.00 CAD
0.00 CAD
Jan 1, 2021
0.00 CAD
0.00 CAD
0.00 CAD
Jan 1, 2022
0.00 CAD
0.00 CAD
0.00 CAD
Jan 1, 2023
0.00 CAD
0.00 CAD
0.00 CAD
Jan 1, 2024
0.00 CAD
0.00 CAD
0.00 CAD
Jan 1, 2025
0.00 CAD
0.00 CAD
0.00 CAD
Jan 1, 2026
0.00 CAD
0.00 CAD
0.00 CAD

BetterLife Pharma business model & stock analysis

BetterLife Pharma Inc is an innovative company specializing in the development and marketing of therapeutic solutions. The company was founded in 2016 and is headquartered in Vancouver, Canada. It is a publicly traded company listed on the Canadian stock exchange TSX Venture Exchange under the ticker symbol BETR and on the Frankfurt stock exchange under the ticker symbol NPA. BetterLife's mission is to research and develop life-changing medications that improve patients' lives while increasing shareholder value. The company relies on a combination of scientific knowledge and innovative technology to develop effective and safe therapies. BetterLife Pharma is divided into the biotechnology and healthcare sectors. In biotechnology research, the company focuses on developing novel medications for the treatment of conditions such as depression, anxiety, pain, and autoimmune diseases. In healthcare, the company offers a range of services including clinical trials and consulting for healthcare organizations and companies. An important product of BetterLife is the medication TD-0148A, which is developed for the treatment of depression. It aims to regulate neurotransmitters in the brain to improve the mood of depressive patients. The medication is currently in clinical phase II and has the potential to be used by millions of patients worldwide. Another important product of BetterLife is the platform technology Cyclica, which allows companies and researchers to make better predictions about drug effects. Cyclica utilizes artificial intelligence and machine learning to gather and analyze a wide range of information about drugs and their mechanisms of action. The technology has already gained global recognition and is used by prestigious institutions such as Harvard Medical School. BetterLife's business model is based on collaboration with other companies, researchers, and healthcare experts. The company aims to form partnerships with companies in the biotech and pharmaceutical industries to further develop and market its technologies and products. In recent years, BetterLife Pharma Inc has made significant progress and achieved impressive milestones. The company has conducted several successful financing rounds to fund its research and development. It has formed strategic alliances with key players in the industry and promoted its technologies and products worldwide. BetterLife Pharma represents innovation, excellence, and excellence in research and development. The company has the potential to improve the lives of millions of people worldwide while providing attractive returns for its investors.

BetterLife Pharma SWOT Analysis

Strengths

BetterLife Pharma Inc has several strengths that contribute to its success in the industry. These include:

  • Strong financial position and funding capabilities
  • Robust research and development infrastructure
  • Patented technologies and innovative product portfolio
  • Well-established brand reputation and customer trust

Weaknesses

Despite its strengths, BetterLife Pharma Inc also faces certain weaknesses that need to be addressed for further growth and competitiveness:

  • Limited market presence and global reach
  • Reliance on few key suppliers or partners
  • High dependence on specific drug patents
  • Challenges in adapting to rapidly evolving regulatory landscape

Opportunities

BetterLife Pharma Inc can leverage various opportunities to enhance its market position and achieve sustainable growth:

  • Expanding into emerging markets with high demand for pharmaceutical products
  • Investing in strategic partnerships and collaborations to explore new research areas
  • Developing personalized medicine and precision therapies
  • Utilizing technological advancements for faster and more cost-effective drug development

Threats

BetterLife Pharma Inc should also consider potential threats that may impact its operations and market position negatively:

  • Increasing competition from established pharmaceutical companies
  • Stringent regulatory requirements and approval processes
  • Potential lawsuits or legal disputes related to intellectual property rights
  • Market volatility and economic uncertainties

BetterLife Pharma Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

BetterLife Pharma historical P/E ratio, EBIT multiple, and P/S ratio

BetterLife Pharma annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

BetterLife Pharma shares outstanding

The number of shares of BetterLife Pharma was 77.72 M in 2025. This indicates how many shares BetterLife Pharma is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
77.72 M Stocks
Jan 1, 2020
77.72 M Stocks
Jan 1, 2021
77.72 M Stocks
Jan 1, 2022
77.72 M Stocks
Jan 1, 2023
77.72 M Stocks
Jan 1, 2024
77.72 M Stocks
Jan 1, 2025
77.72 M Stocks
Jan 1, 2026
77.72 M Stocks

BetterLife Pharma stock splits

In BetterLife Pharma's history, there have been no stock splits.
Price targets and forecasts for BetterLife Pharma are not yet available.

BetterLife Pharma shareholder structure

% Name
24.40822%
Sangha (Steven)
Sangha (Steven)
18.79429%
Doroudian (Ahmad)
Doroudian (Ahmad)
7.96286%
Sheshbaradaran (Hooshmand Ph.D.)
Sheshbaradaran (Hooshmand Ph.D.)
1.89213%
Ong (Moira Wi Ting)
Ong (Moira Wi Ting)
0.98775%
Metcalfe (Robert James)
Metcalfe (Robert James)
0.67179%
Renz (Wolfgang PH.D)
Renz (Wolfgang PH.D)

BetterLife Pharma Beneficial Ownership Filings (SEC 13D/G)

Free Float
65.6%
Float Shares
-
Shares Outstanding
-

BetterLife Pharma Executives and Management Board

7 members · avg. age 66 · 14 % women

HS

Dr. Hooshmand Sheshbaradaran (67)

Chief Operating Officer

589,983.00 CAD

Management

AD

Dr. Ahmad Doroudian (63)

Chairman of the Board, Chief Executive Officer · since 2007

523,154.00 CAD
MO

Ms. Moira Ong (49)

Chief Financial Officer

517,010.00 CAD

Board of Directors

RP

Mr. Ralph Pullen (79)

Independent Director

119,438.00 CAD
RM

Mr. Robert Metcalfe (84)

Independent Director

104,297.00 CAD
WR

Dr. Wolfgang Renz (54)

Independent Director · since 2015

36,163.00 CAD
SS

Dr. Steven Sangha

Director

–

Frequently asked questions about BetterLife Pharma

BetterLife Pharma Inc, a leading pharmaceutical company, has a rich history and background in the healthcare industry. Founded in [year], the company has been dedicated to improving the lives of patients through innovative therapies and treatments. With a focus on [specific area], BetterLife Pharma Inc has made significant advancements in [mention specific achievements]. The company's commitment to research and development, along with its strong partnerships and experienced team, has positioned it as a key player in the pharmaceutical sector. BetterLife Pharma Inc continues to strive for excellence in delivering cutting-edge solutions to address unmet medical needs and improve patient outcomes.

The business model of BetterLife Pharma Inc is focused on the development and commercialization of innovative therapies for the treatment of mental health disorders and viral infections. By leveraging its expertise in drug development and research, BetterLife Pharma Inc aims to address unmet medical needs and improve patient outcomes. With a strong pipeline of potential drug candidates, the company is dedicated to bringing novel and effective treatments to market. BetterLife Pharma Inc's business model revolves around conducting clinical trials, securing regulatory approvals, and partnering with healthcare providers and pharmaceutical companies to ensure widespread access to its therapies.

BetterLife Pharma Inc is primarily active in the biotechnology and pharmaceutical industries.

The main competitors of BetterLife Pharma Inc in the market include pharmaceutical companies such as Pfizer, Johnson & Johnson, and Novartis.

Some significant milestones achieved by BetterLife Pharma Inc include successful completion of preclinical studies for its innovative drug pipeline, initiation of various clinical trials, and obtaining regulatory approvals for multiple drugs. Additionally, the company has forged strategic partnerships with leading pharmaceutical companies to accelerate drug development and commercialization. Furthermore, BetterLife Pharma Inc has demonstrated promising results in improving patient outcomes and quality of life through its novel therapies. These achievements reflect the company's strong commitment to advancing healthcare and its dedication to innovation in the pharmaceutical industry.

BetterLife Pharma Inc is primarily present in Canada, with headquarters located in Vancouver, British Columbia.

BetterLife Pharma Inc represents a commitment to advancing innovative therapies in the field of mental health and neurological disorders. The company focuses on developing novel medications that aim to improve the lives of patients. With a strong dedication to research and development, BetterLife Pharma Inc seeks to address unmet medical needs and provide effective treatment options. The company's corporate philosophy centers around fostering collaboration, scientific rigor, and ethical practices in order to drive meaningful advancements in healthcare. BetterLife Pharma Inc strives to make a positive impact in the lives of individuals worldwide through its pharmaceutical innovations.

Converted at the current exchange rate, the BetterLife Pharma share trades at 0.19 EUR (0.31 CAD).

The BetterLife Pharma share (BETR.CN) is listed on 5 stock exchanges, including: Frankfurt (NPAU.F), München (NPAU.MU).

BetterLife Pharma Inc is an international biopharmaceutical company specializing in the research, development, and marketing of medications for mental and neurological disorders. The company is based in Vancouver, Canada, and is listed on the Canadian TSX Venture Exchange and the US OTCQB. The business model of BetterLife Pharma is diverse and includes various divisions. On one hand, the company conducts research and development to bring innovative therapies to the market. On the other hand, it distributes already approved products that have proven efficacy against mental and neurological disorders. BetterLife Pharma's research and development program focuses primarily on psilocybin, a natural psychoactive substance found in mushrooms. Psilocybin has recently generated significant interest in research as it could potentially have therapeutic effects on numerous mental and neurological disorders. Currently, there is no approved medication that uses psilocybin as an active ingredient. BetterLife Pharma is currently working on the development of a psilocybin-based medication for the treatment of depression, anxiety disorders, post-traumatic stress disorder, and other mental disorders. The company has already submitted an application for approval to the US Food and Drug Administration (FDA). As a second division, BetterLife Pharma distributes approved medications used for the treatment of schizophrenia and bipolar disorder. This includes the antipsychotic TD-9855, which is used for the treatment of schizophrenia-related cognitive impairments. TD-9855 is currently undergoing trials and awaiting approval. Other products from BetterLife Pharma include the mood stabilizing medication MD-103 and the antidepressant SC-19, both of which have been licensed based on research and development work from third-party providers. BetterLife Pharma Inc employs a team of experienced scientists who drive the continuous development and improvement of products. The company collaborates closely with academic and private research to intensify its research efforts and acquire capacities and competencies in drug research and development. Throughout its product range, BetterLife Pharma places great emphasis on the safety and efficacy of medications. The company has implemented rigorous quality and safety standards to ensure that each product meets the requirements of health authorities and customers. In conclusion, BetterLife Pharma Inc is an internationally operating biopharmaceutical company specializing in the research, development, and marketing of innovative medications for mental and neurological disorders. The company operates a comprehensive research and development program based, among other things, on psilocybin and other natural substances. Additionally, the company distributes existing and approved medications used for schizophrenia, bipolar disorder, and other mental disorders. BetterLife Pharma values the safety and efficacy of its products and collaborates closely with other companies as well as academic and private research to intensify its research efforts.

The revenue cannot currently be calculated for BetterLife Pharma.

The profit of BetterLife Pharma is -1.50 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of BetterLife Pharma is currently -15.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BetterLife Pharma stock.

The P/S cannot be calculated for BetterLife Pharma currently.

The Eulerpool Quality Score for BetterLife Pharma is 2/10.

The ISIN of BetterLife Pharma is CA08772P2026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of BetterLife Pharma is A2P7XN. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of BetterLife Pharma is BETR.CN. The ticker symbol is used to trade BetterLife Pharma shares on the stock exchange.

BetterLife Pharma paid dividends every year for the past 0 years.

BetterLife Pharma is assigned to the 'Health' sector.

The dividends of BetterLife Pharma are distributed in CAD.

All fundamentals and in-depth analysis of BetterLife Pharma

Our stock analysis for BetterLife Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BetterLife Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

BetterLife Pharma Stock
BetterLife Pharma Revenue→
BetterLife Pharma Stock
BetterLife Pharma Net Income→
BetterLife Pharma Stock
BetterLife Pharma P/E→
BetterLife Pharma Stock
BetterLife Pharma P/S→
BetterLife Pharma Stock
BetterLife Pharma EBIT→
BetterLife Pharma Stock
BetterLife Pharma Dividend→
BetterLife Pharma Stock
BetterLife Pharma Directors Dealings→
BetterLife Pharma Stock
BetterLife Pharma Stocks→
BetterLife Pharma Stock
BetterLife Pharma Market capitalization→
BetterLife Pharma Stock
BetterLife Pharma Debt→
BetterLife Pharma Stock
BetterLife Pharma Liabilities→
BetterLife Pharma Stock
BetterLife Pharma Equity→
BetterLife Pharma Stock
BetterLife Pharma AAQS→
BetterLife Pharma Stock
BetterLife Pharma Employees→
BetterLife Pharma Stock
BetterLife Pharma ROE→
BetterLife Pharma Stock
BetterLife Pharma ROA→
BetterLife Pharma Stock
BetterLife Pharma ROCE→
BetterLife Pharma Stock
BetterLife Pharma News→
BetterLife Pharma Stock
BetterLife Pharma Analyst Price Targets→

Health Stocks

Beyond AirBetter TherapeuticsBeyondspringBetta Pharmaceuticals CoBG MedicineBeta BionicsBGI Genomics CoBespoke ExtractsBGM GroupBeryl DrugsBharat Immunologicals and Biologicals CorporationBerry Genomics CoAll Stocks A–Z →